High materiality7/10
Teva initiated with a Market Perform at Leerink
Why it may matterVerify against the original reporting
Significant upside potential.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Leerink initiates Teva with an Outperform; target $45 vs current $36.76.
- Teva Outperform initiation; target 45 vs 36.76.
Key facts
- 01
Target: $45
- 02
Posted price: $36.76
- 03
Analyst firm: Leerink Partners
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.